Sign in with Facebook
Or use your Businessweek account
Or use your Businessweek account
Already a Bloomberg.com user?
Sign in with the same account.
Businessweek Archives
Genentech Herceptin
Posted on December 20, 1998
Special Report
GENENTECH HERCEPTIN
Genentech's Herceptin is the first drug to target a cancer-causing genetic defect. It blocks a gene found in 30% of breast-cancer victims. (800) 626-3553
Feed
Most Popular
- The Genetically Modified Burrito: Chipotle Tells All
- America's 50 Best Cities
- Want to Draw a Crowd? Offer to Charge Phones
- Ancient Roman Concrete Is About to Revolutionize Modern Architecture
- A New Push to Sell the World's Biggest Jet
- Five Questions Edward Snowden Didn't Answer
- Debating Bitcoin: Will the Cryptocurrency's Merits Be Its Undoing?
- The Logic Behind P&G's Old-School Manhattan Giveaway
- The Genetically Modified Burrito: Chipotle Tells All
- Want to Draw a Crowd? Offer to Charge Phones
- Ancient Roman Concrete Is About to Revolutionize Modern Architecture
- America's 50 Best Cities
- Think the Internet Leads to Growth? Think Again
- Debating Bitcoin: Will the Cryptocurrency's Merits Be Its Undoing?
- Why Yahoo! Partnered With the 49ers' New Levi's Stadium
- Darrell Issa's IRS Investigation Is Falling Apart
- Renaming the Redskins: 4 New, Not-Racist Names and Logos for D.C.'s NFL Team
- Ancient Roman Concrete Is About to Revolutionize Modern Architecture
- Bill Clinton on Helping U.S. Homeowners Adopt Solar Energy
- Five Questions Edward Snowden Didn't Answer
- The Genetically Modified Burrito: Chipotle Tells All
- States Move to Ban Credit Screening for Job Applicants
- Fannie and Freddie Are Super-Profitable, but Congress Doesn't Care
Ads by Google
Elsewhere on Businessweek.com
-
Fix This/Water
-
Nascar, Looking for Tech Update, Invites HP Into Its Pit Crew
-
Google Glass Is Already Here...on the Battlefield
-
The Logic Behind P&G's Old-School Manhattan Giveaway
-
Flying Polar Bears: Inside UPS's Billion-Dollar Hub
-
Debating Bitcoin: Will the Cryptocurrency's Merits Be Its Undoing?
-
A Trademark Law Startup Wants to Be Like Yelp
-
Inside Bloomberg's 24 Hour Hackfest
-
What's Harley-Davidson Doing in Vatican City?
-
A Look at the Future of Wearable Computing
-
New Fords to Be Full of Knobs
-
A Free BMW Is Nice, But a Raise Is Better
Links
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC Ad Choices